Analyst Ratings for United Therapeutics Corp. (UTHR)
UTHR Rating Summary
UTHR Price Target Summary
- Highest: $738.00 (Wells Fargo)
- Lowest: $516.00 (Morgan Stanley)
- Average: $654.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$654.92 (+19.6%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
685.00 (N/A) |
566.99 (547.69) |
-3.4% | Details |
| 5/7/2026 | Wells Fargo | Ben Burnett | Upgrade | Overweight (Equal Weight) |
738.00 (575.00) |
596.76 (547.69) |
-8.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
